AtriCure, Inc. , a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced ...

Boston Scientific, Medtronic, Abbott and J&J unveiled new data for their PFA devices in tandem with the Heart Rhythm ...

Researchers sought to determine 1-year outcomes in patients being treated with tirzepatide who have atrial fibrillation.

“It was an experience that dramatically improved my life,” said Mike Prescott of Kenosha, who retired a couple of years ago ...

Not all strokes are equally devastating, and new research shows that certain health risks don’t just increase your chances of ...

Clinical risk models for predicting risk for atrial fibrillation following stroke may be improved with the addition of a polygenic risk score.

SGLT2 inhibitors, compared with GLP1 agonists, significantly lower risk for atrial fibrillation in patients with type 2 diabetes.

For patients newly diagnosed with atrial fibrillation during hospitalization for other causes, most are not dispensed anticoagulants in the year after discharge.

Researchers sought to determine the relationship among hospitalization for COPD exacerbation, AF burden, and risk for subsequent stroke.

GLP-1 use significantly lowered risk for atrial fibrillation-related events for patients with diabetes, AF and obesity, with ...

The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.

(HealthDay News) — Average and brisk walking pace are associated with a decreased risk for cardiac arrhythmias, according to a study published online April 15 in Heart.